Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
Sign Up to like & getrecommendations! Published in 2019 at "JAMA Neurology"
DOI: 10.1001/jamaneurol.2018.4249
Abstract: Importance Racial differences in molecular biomarkers for Alzheimer disease may suggest race-dependent biological mechanisms. Objective To ascertain whether there are racial disparities in molecular biomarkers for Alzheimer disease. Design, Setting, and Participants A total of… read more here.
Keywords: alzheimer disease; total tau; disease; biomarkers alzheimer ... See more keywords
Acceptability and feasibility of plasma phosphorylated‐tau181 in two memory services
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Geriatric Psychiatry"
DOI: 10.1002/gps.5897
Abstract: Plasma phosphorylated‐tau181 (p‐tau181) represents a novel blood‐based biomarker of Alzheimer's disease pathology. We explored clinicians' experience of the utility of plasma p‐tau181 in Camden and Islington Memory Services. read more here.
Keywords: acceptability feasibility; phosphorylated tau181; memory services; plasma ... See more keywords
Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum
Sign Up to like & getrecommendations! Published in 2020 at "Brain"
DOI: 10.1093/brain/awaa399
Abstract: See Tijms and Teunissen (doi:10.1093/brain/awaa422) for a scientific commentary on this article. Plasma phosphorylated tau181 may be an accessible and scalable biomarker for Alzheimer’s disease. Moscoso et al. examine the time course of changes in… read more here.
Keywords: alzheimer disease; time course; disease; disease spectrum ... See more keywords